Tuberculosis research

Tuberculosis research

Tuberculosis is the leading cause of death from a single infectious agent and remains a global health emergency. In 2018 alone, there were 1.5 million deaths and 10 million new cases globally, among whom half a million had rifampicin resistant TB. The annual rate of decline in TB incidence is still much lower than what would be needed to end the TB epidemic by 2030.

It is critical to identify and overcome barriers to effective implementation of existing strategies and tools, which, if adequately employed, would drastically reduce the TB burden. Implementation research on best strategies for early diagnosis, treatment and prevention of TB, optimized and tailored to various socioeconomic contexts and responsive to local conditions, would help accelerate the decline in TB incidence rates globally. This is particularly essential in resource-limited settings where much remains to be done to achieve universal coverage for TB care. Implementation research on effective approaches that can mobilize sustained community engagement, address social determinants of TB and strengthen political commitment remains an important area to End TB.

WHO’s End TB Strategy, endorsed by the World Health Assembly in May 2014, distinctly recognized TB research as one of its three pillars. Locally owned and conducted implementation TB research within national TB programmes are needed in countries to identify more efficient ways of using existing tools and expeditiously scaling up new tools to End TB.

TDR aims to contribute to the End TB effort by conducting and enhancing capacity for implementation research at national, regional and global levels.
   

Our work

Calibrating computer-aided detection (CAD) for TB

Calibrating computer-aided detection (CAD) for TB

Overview

A research toolkit to support the effective use of computer-aided detection (CAD) software for TB by calibrating CAD score thresholds and other parameters. 

Chest radiography (CXR) plays a key role in the screening and triage of pulmonary tuberculosis (TB) and can guide the effective use of diagnostic testing to improve case detection and cost-efficiency.  Computer-aided detection (CAD) products use artificial intelligence (AI) to analyse CXR for the presence of abnormalities suggestive of pulmonary TB and can improve the feasibility and performance of CXR for TB screening and triage.  CAD technologies for TB detection have recently been recommended for use by WHO among adults aged 15 years or more, in place of human readers for interpretation of digital chest radiography in both screening and triage for TB disease.

CAD products produce an abnormality score that can be used to signal probable TB and trigger further TB diagnostic evaluation relative to a selected threshold. Identifying an appropriate threshold requires the calibration of CAD products based on the local context and intended use, as well as decision making around the goals for screening and acceptable costs.

Featured publications

View all →
TDR annual report 2024

This report highlights the impact of research supported by the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases...

TDR annual report 2023

This report highlights the impact of research supported by the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases...

TDR annual report 2022

This report highlights the impact of research supported by the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases...

Videos